AGP Executive Report
Last update: 6 hours agoHospice exit: Humana signed a deal to sell its remaining minority stake in Gentiva, valuing it at about $900M, as the insurer completes its exit from hospice and palliative care; the sale is expected to close in Q3 2026 pending approvals. Drug safety: The FDA announced a recall of duloxetine bottles due to a potentially cancer-causing impurity above safety limits, warning that long-term exposure to nitrosamine impurities may raise cancer risk. Food & environment: A new review links the insecticide chlorpyrifos to multi-organ damage and chronic disease, prompting renewed EPA reassessment of whether it should stay approved for major crops. Brain health: A large Japanese study found drinking green tea (around three cups daily) was linked to fewer dementia-related brain lesions, with benefits not seen in everyone. AI in healthcare: Doctors warn AI chatbots can sound confident while giving wrong or incomplete medical advice, urging people not to replace clinicians. Community care: RWJBarnabas Health and Union County are launching a mobile pediatric unit to bring screenings, vaccines, and preventive care to underserved neighborhoods. Medication aftercare: Coverage on life after stopping Ozempic highlights common rebound weight gain and the need for support and healthy habits.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.